光照敏感度多基因评分×月相:从单个基因到整张评分表,能否预测谁被月亮牵动?

Written by

in

Language

Evidence level: B

上一篇提出”MTNR1B 基因型可能决定谁被月亮牵动”,但单个位点解释不了多少——光敏感度本身是一个高度可遗传、个体差异跨一个数量级的性状。把它升级为”多基因评分×月相”交互,才是这条线真正能站住的检验设计。

正文

先说为什么必须从”单基因”升级到”评分表”。光敏感度是一个可遗传且个体差异巨大的性状,这一点早有硬证据:双生子研究显示,夜间强光下的褪黑素抑制敏感度与褪黑素分泌动力学本身都有显著遗传成分(PMID 16769177)。而差异的幅度更是惊人——同一强度的傍晚光照,不同个体触发褪黑素抑制的半数有效照度(ED50)可以跨越一个数量级,从十几 lux 到几百 lux 不等(PMID 31138694)。换句话说,”你有多怕光”这件事,人和人之间差得不是一点半点。褪黑素抑制对光的反应极其灵敏、且主要由视网膜的 melanopsin(黑视蛋白)通路驱动(PMID 30697806)。系统综述把这条线总结得很清楚:个体光敏感度差异是睡眠与昼夜节律个体差异的核心来源之一(PMID 33049062)。

问题是,这个”敏感度”的遗传基础至今基本是空的。直到 2022 年 Burns 等人在 28 万人中做了全基因组”基因×光照”交互扫描(GWIS),才第一次定位到显著位点:ARL14EP 的 rs3847634,携带更多次要等位的人,日照对”晨型化”的推动更强(βGxE = −0.03,SE = 0.005);该位点同时是脑与视网膜组织中 ARL14EP 表达增强的 eQTL(PMID 36519390)。这个结果极其重要,但请注意效应量之小:单个位点的交互项 β 只有 0.03 的量级。GWIS 的富集分析还提示,光敏感度位点集中在 G 蛋白偶联谷氨酸受体信号通路、以及表达 Per2 的下丘脑(SCN)神经元里——也就是说,真正起作用的是一批位点的合力,而非某一个”月亮基因”。

这一步”从单点到全基因组”的跨越,在计时型(chronotype)研究里已经走完了。计时型的大规模 GWAS 已在近 70 万人中识别出数百个位点(PMID 30696823);在此基础上构建的多基因评分(PRS/PGS)已被证明可携带、有预测力:睡眠时长 PRS 的最高与最低 5% 分位之间,报告睡眠时长相差 22.2 分钟(PMID 36648941);晨型 PGS 可稳定预测晨型本身(R² ≈ 1.55%)并外溢预测抑郁症状(PMID 38425306);甚至有研究用 19 个昼夜节律基因的靶向测序构建出预测效度约 80% 的”分子计时型”评分面板(PMID 35583112)。方法学上,用 PRS 去做基因-环境交互也已成套:IPRS 直接利用 GxE 结构重构评分(PMID 35401709)、通路水平 PRS 专为交互设计(PMID 40763299)、以及针对 GxE PRS 中 I 类错误膨胀与功效损失的系统校正方案(PMID 38303123)。已有 GxE 分析支持”晚型在特定环境下反而睡得更久”这类方向性结论(PMID 36745570),说明环境修饰效应能被真实检出。

把三条线接起来,本主题的命题是这样的:把”光敏感度”从单基因升级为多基因总分,用该评分与月相的交互项,去预测个体对月相-睡眠耦合的反应强度。 它与上一篇的区别很关键——上一篇问的是”某个位点的交互方向是放大还是缓冲”,本篇问的是”加总之后,评分能不能真的提高预测力“。这是一个纯粹的增量价值问题,而不是方向问题。

设计上可以做三层检验。第一层是增益检验:在同一个纵向队列里,分别拟合”月相 × rs3847634″与”月相 × 光敏感度 PRS”两组模型,比较 ΔR²、ΔAIC 与似然比——如果 PRS 不带来任何增量,说明光敏感度对月相反应没有净贡献,这正是最强的证伪条件。第二层是分位梯度检验:若假设成立,PRS 按十分位分层后,月相-睡眠关联强度应呈单调递增(或递减)的梯度,而不是只有极端两端有差异。第三层是可移植性检验:PRS 权重必须来自独立样本的 GWIS 摘要统计,然后在目标队列中投影——若用同一批样本既选位点又算评分,会因 winner’s curse 系统性高估效应。队列要求也不低:每人至少覆盖 3 个以上完整月相周期(约 3 个月)的腕表活动记录或 PSG,配合基因分型与可核算的夜间光照暴露代理(地理位置 + 云量 + 室内照度实测)。

这条路线最大的陷阱不是统计,而是混杂。月相相位与月出/月落时间随季节与纬度系统性漂移,因此月相变量天然与季节、日照时长、作息季节漂移共线;如果只按相位打标签而不控制季节与纬度,很容易把季节效应误读成月光效应。此外,光照暴露的测量误差会系统性稀释交互项(attenuation),PRS 的跨族裔可移植性也远未解决。因此这项检验的合格线不只是”显著”,而是在控制季节/纬度/云量后仍显著、且增量优于单基因、并在独立队列中复现。

对”天人相应”这层意思,这个设计的落点其实很朴素:古人讲”八字禀赋”,从来不是指某一个字的吉凶,而是整张表的格局。光敏感度也一样——它不是一个开关键,是一条连续谱,由几百个位点的合力决定。你被月亮牵动多少,不取决于你有没有那个”月亮基因”,而取决于你这张评分表落在谱上的哪一段。

证据与局限

已验证: 光敏感度是可遗传性状(褪黑素抑制敏感度与分泌动力学均有显著遗传度);个体光敏感度差异巨大(ED50 跨一个数量级),褪黑素抑制极灵敏且由 melanopsin 主导;GWIS 已定位光敏感度位点(ARL14EP rs3847634;富集于谷氨酸信号与 Per2+ SCN 神经元)但单点效应量极小(βGxE≈0.03);计时型 GWAS 已达 70 万人量级,多种睡眠/昼夜节律 PRS 已被证实可携带且有预测力;用 PRS 做 GxE 交互的方法学(IPRS、通路 PRS、I 类错误校正)已成熟。

部分验证: “光敏感度可由多基因评分有效刻画”这一前提,目前只有单点 GWIS 与计时型 PRS 的间接支持,尚无直接构建并验证过”光敏感度 PRS”;PRS × 月相交互的预测增益从未被检验;GxE 交互项方差小、需要极大样本与良好光照测量精度,实际可检性存疑。

待验证: 核心假设”光敏感度 PRS × 月相的交互项显著、且增量优于单基因交互”完全未被检验;PRS 分层后月相-睡眠关联是否呈单调梯度未定;跨队列可移植性(尤其非欧洲祖先人群)未知;月相与季节/纬度的共线能否被充分解耦,尚无先例可参照。

相关阅读

证据等级: B
参考文献: PMID 16769177, PMID 31138694, PMID 30697806, PMID 33049062, PMID 36519390, PMID 30696823, PMID 36648941, PMID 38425306, PMID 35583112, PMID 35401709, PMID 40763299, PMID 38303123, PMID 36745570


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Light Sensitivity Polygenic Score × Lunar Phase: From Single Genes to a Comprehensive Scorecard, Can We Predict Who Is Influenced by the Moon?

Evidence level: B

The previous article proposed that “MTNR1B genotype may determine who is ‘touched’ by the moon,” but a single locus explains very little—light sensitivity itself is a highly heritable trait with inter-individual differences spanning an order of magnitude. Upgrading this to a “multigene score × lunar phase” interaction is the only design that truly holds for this line of inquiry.

Main Text

First, why we must upgrade from “single gene” to a “scorecard.” Light sensitivity is a heritable trait with massive inter-individual variation, a fact supported by hard evidence: twin studies show that melatonin suppression sensitivity under bright night light and the melatonin secretion dynamics themselves both have significant genetic components (PMID 16769177). The magnitude of this variation is staggering—under the same evening light intensity, the half-effective dose (ED50) triggering melatonin suppression can vary across an order of magnitude, ranging from tens to hundreds of lux (PMID 31138694). In other words, the extent to which “you fear light” varies between individuals is not merely a half-and-half difference. Melatonin suppression responds extremely sensitively to light and is primarily driven by the retinal melanopsin (black opsin) pathway (PMID 30697806). Systematic reviews summarize this line clearly: inter-individual differences in light sensitivity are a core source of variation in sleep and circadian rhythms (PMID 33049062).

The problem is that the genetic basis of this “sensitivity” remains largely empty until 2022, when Burns et al. conducted a whole-genome “gene × light” interaction scan (GWIS) in 280,000 people, finally identifying a significant locus: rs3847634 in ARL14EP. Individuals carrying more minor alleles showed a stronger push toward “morningness” in response to daylight (βGxE = −0.03, SE = 0.005); this locus is also an eQTL for enhanced ARL14EP expression in both brain and retinal tissues (PMID 36519390). This result is extremely important, but note the tiny effect size: the interaction term β for a single locus is only on the order of 0.03. GWIS enrichment analysis also suggests that light sensitivity loci cluster within the G-protein coupled glutamate receptor signaling pathway and in Per2-expressing hypothalamic (SCN) neurons—meaning the true driver is the collective force of a set of loci, not a single “moon gene.”

This leap from “single point” to “whole genome” has already been completed in chronotype research. Large-scale GWAS for chronotypes have identified hundreds of loci in nearly 700,000 individuals (PMID 30696823); polygenic scores (PRS/PGS) built on this foundation have been proven portable and predictive: the difference in reported sleep duration between the highest and lowest 5% percentiles of sleep duration PRS is 22.2 minutes (PMID 36648941); morningness PGS can stably predict morningness itself (R² ≈ 1.55%) and spill over to predict depressive symptoms (PMID 38425306); even studies using targeted sequencing of 19 circadian rhythm genes constructed a “molecular chronotype” score panel with ~80% predictive validity (PMID 35583112). Methodologically, using PRS for gene-environment interaction is now a standard toolkit: IPRS directly reconstructs scores using GxE structure (PMID 35401709), pathway-level PRS is designed specifically for interactions (PMID 40763299), and systematic correction schemes for Type I error inflation and power loss in GxE PRS exist (PMID 38303123). Existing GxE analyses support directional conclusions such as “late types sleep longer in specific environments” (PMID 36745570), demonstrating that environmental modification effects can be truly detected.

Connecting these three lines, the proposition of this topic is as follows: upgrade “light sensitivity” from a single gene to a total polygenic score, and use the interaction between this score and lunar phase to predict individual reaction intensity to moon-phase-sleep coupling. The distinction from the previous article is crucial—the previous one asked whether “the interaction direction of a specific locus amplifies or buffers,” while this one asks “whether aggregation truly improves predictive power.” This is a pure question of incremental value, not direction.

Three layers of testing can be designed. First is a gain test: within the same longitudinal cohort, fit two models separately—”lunar phase × rs3847634″ and “lunar phase × light sensitivity PRS”—and compare ΔR², ΔAIC, and likelihood ratios. If the PRS brings no incremental gain, it indicates light sensitivity contributes no net effect to lunar phase response; this is the strongest falsification condition. Second is a quantile gradient test: if the hypothesis holds, after stratifying PRS by deciles, the strength of the lunar-phase-sleep association should show a monotonic increasing (or decreasing) gradient, rather than differences only at the extremes. Third is a portability test: PRS weights must come from summary statistics of GWIS in independent samples, then projected into the target cohort. Using the same samples to select loci and calculate scores will systematically overestimate effects due to the winner’s curse. The cohort requirements are not low: each person must cover at least three complete lunar cycles (approx. 3 months) of wrist activity records or PSG, combined with genotyping and calculable proxies for nocturnal light exposure (geographic location + cloud cover + measured indoor illuminance).

The biggest trap on this route is not statistics but confounding. Lunar phase drifts systematically with season and latitude due to moonrise/moonset times; therefore, the lunar phase variable is naturally collinear with season, daylight duration, and seasonal circadian drift. If one merely labels by phase without controlling for season and latitude, seasonal effects are easily misread as lunar effects. Furthermore, measurement error in light exposure systematically dilutes the interaction term (attenuation), and cross-ancestry portability of PRS remains unresolved. Therefore, the passing grade for this test is not just “significant,” but significant after controlling for season/latitude/cloud cover, with incremental gain superior to single-gene interaction, and replicated in independent cohorts.

Regarding the layer of “Heaven and Man Correspondence,” the landing point of this design is actually quite plain: ancient texts discuss “Eight Characters endowment” (Bazi), never referring to the auspicious or inauspicious nature of a single character, but rather the overall pattern of the entire chart. Light sensitivity is the same—it is not a switch, but a continuum determined by the collective force of hundreds of loci. How much you are “touched” by the moon does not depend on whether you possess that specific “moon gene,” but rather which segment of the spectrum your scorecard falls into.

Evidence and Limitations

Verified: Light sensitivity is a heritable trait (both melatonin suppression sensitivity and secretion dynamics show significant heritability); inter-individual differences in light sensitivity are massive (ED50 spans an order of magnitude), melatonin suppression is extremely sensitive and melanopsin-dominated; GWIS has located light sensitivity loci (ARL14EP rs3847634; enriched in glutamate signaling and Per2+ SCN neurons) but single-point effect sizes are negligible (βGxE≈0.03); chronotype GWAS has reached the 700,000-person scale, and multiple sleep/circadian PRS have been proven portable and predictive; methodological tools for GxE interaction using PRS (IPRS, pathway PRS, Type I error correction) are mature.

Partially Verified: The premise that “light sensitivity can be effectively characterized by a polygenic score” currently has only indirect support from single-point GWIS and chronotype PRS, with no direct construction and validation of a “light sensitivity PRS”; predictive gain of PRS × lunar phase interaction has never been tested; GxE interaction terms have small variance, requiring massive samples and high light measurement precision, making practical detectability questionable.

To Be Verified: The core hypothesis “interaction term of light sensitivity PRS × lunar phase is significant and incrementally superior to single-gene interaction” remains completely untested; whether a monotonic gradient exists for lunar-phase-sleep association after PRS stratification is undetermined; cross-cohort portability (especially in non-European ancestral populations) is unknown; whether collinearity between lunar phase and season/latitude can be fully decoupled has no precedents to reference.

Related Reading

Evidence Level: B
References: PMID 16769177, PMID 31138694, PMID 30697806, PMID 33049062, PMID 36519390, PMID 30696823, PMID 36648941, PMID 38425306, PMID 35583112, PMID 35401709, PMID 40763299, PMID 38303123, PMID 36745570


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *